Terns Pharmaceuticals Inc (TERN) — Strategic Asset Allocation Index
Terns Pharmaceuticals Inc (TERN) has a Strategic Asset Allocation Index of 0.2% as of June 2023. Strategic assets (PP&E of $590.00K plus long-term investments of $-) total $590.00K, measured against net assets of $274.15 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. For live market cap and overall valuation, see Terns Pharmaceuticals Inc (TERN) market capitalisation.
SAAI
Strategic Assets
PP&E
Net Assets
Terns Pharmaceuticals Inc Strategic Asset Allocation Index (2018–2022)
This chart shows how Terns Pharmaceuticals Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2018 to 2022. As of June 2023, the index stands at 0.2%, representing strategic assets of $590.00K against net assets of $274.15 Million USD. See TERN equity financing ratio to measure how much of total assets are equity-financed.
Annual Strategic Asset Allocation Index for Terns Pharmaceuticals Inc (2018–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Terns Pharmaceuticals Inc from 2018 to 2022, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. Also explore net asset growth rate of Terns Pharmaceuticals Inc to track the company's year-over-year net asset growth rate.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 0.3% | $757.00K | $757.00K | $- | $276.94 Million | ▼ -0.4 pp |
| 2021 | 0.7% | $1.05 Million | $1.05 Million | $- | $160.30 Million | ▼ -1.1 pp |
| 2020 | 1.7% | $1.18 Million | $1.18 Million | $- | $68.59 Million | ▼ -3.5 pp |
| 2019 | 5.2% | $961.00K | $961.00K | $- | $18.32 Million | ▲ +4.9 pp |
| 2018 | 0.4% | $261.00K | $261.00K | $- | $72.23 Million | — |